… In conclusion, within 8 years of HPV vaccine introduction in the United States, we … cervical
precancers caused by HPV vaccine types among 18–39 year-old women. Among vaccinated …

… human papillomavirus vaccine are in regions of Africa and Asia where the burden of cervical
… on the impact of human papillomavirus vaccination on cervical pre-cancer and, potentially, …

… prevented 100% of moderate and severe precancerous cervical lesions associated with
types 16 or 18 among women with no previous infection with these types. A bivalent (types 16 …

… between the acquisition of HPV infection and precancer development, and only … HPV as
the cause of cervical cancer and other diseases therefore implied that an effective HPV vaccine …

… human papillomavirus (HPV)-related disease burden globally. In many countries where
prophylactic HPV vaccination … a 90% vaccine efficacy in protection against cervical pre-cancer in …

… types pre-vaccination, some form of cervical precancer screening will still be necessary. …
cervical precancerous lesions or genital warts seen with no reinfection or new exposure to HPV …

… of cervical precancerous lesions) has the potential to eliminate … that HPV vaccination reduces
the incidence rate of cervical cancer by 86% and 68% among girls and women vaccinated …

… precancerous lesions. In this review, we present the updated information about current HPV
vaccines, focusing on vaccine … cervical precancerous lesions regardless of HPV infection or …

… Model projections on impact and cost-effectiveness of HPV vaccination The population
impact of HPV vaccination programmes in preventing cervical precancerous lesions and cancer, …

… human papillomavirus (HPV) genotyping particularly vaccine genotypes and multiple infections
for cervical precancer … screening strategy and assessing potential effects of HPV vaccine. …